Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,077 | 114 | 96.6% |
| Education | $72.29 | 6 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $273.99 | 14 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $254.34 | 19 | $0 (2022) |
| Amgen Inc. | $161.20 | 6 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $159.42 | 10 | $0 (2024) |
| Relypsa, Inc. | $151.78 | 10 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $98.86 | 4 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $93.88 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $88.70 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $83.12 | 6 | $0 (2022) |
| Travere Therapeutics, Inc. | $75.84 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $730.51 | 36 | Bayer Healthcare Pharmaceuticals Inc. ($141.11) |
| 2023 | $224.32 | 12 | Otsuka America Pharmaceutical, Inc. ($130.27) |
| 2022 | $157.26 | 10 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($65.85) |
| 2021 | $99.28 | 6 | Novartis Pharmaceuticals Corporation ($38.47) |
| 2020 | $82.51 | 7 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($55.59) |
| 2019 | $319.62 | 20 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($120.72) |
| 2018 | $184.67 | 9 | Amgen Inc. ($56.29) |
| 2017 | $350.63 | 20 | Relypsa, Inc. ($117.14) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $24.94 | General |
| Category: NEPHROLOGY | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Cardio-renal | ||||||
| 11/27/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $22.44 | General |
| Category: NEPHROLOGY | ||||||
| 11/25/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Nephrology | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: NEPHROLOGY | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $32.01 | General |
| 09/18/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: Hematology | ||||||
| 09/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Cardio-renal | ||||||
| 09/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $17.77 | General |
| Category: NEPHROLOGY | ||||||
| 08/22/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: NEPHROLOGY | ||||||
| 08/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Cardio-renal | ||||||
| 08/08/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $41.53 | General |
| Category: Hematology | ||||||
| 08/07/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: NEPHROLOGY | ||||||
| 08/01/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $28.58 | General |
| 08/01/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $7.41 | General |
| 07/22/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/16/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: HEMATOLOGY | ||||||
| 07/10/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Nephrology | ||||||
| 07/02/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: NEPHROLOGY | ||||||
| 06/10/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: NEPHROLOGY | ||||||
| 06/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Cardio-renal | ||||||
| 06/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 433 | 818 | $167,398 | $62,175 |
| 2022 | 4 | 302 | 676 | $142,710 | $43,061 |
| 2021 | 8 | 502 | 1,018 | $194,207 | $68,649 |
| 2020 | 7 | 599 | 1,162 | $191,722 | $74,715 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 160 | 447 | $70,146 | $26,608 | 37.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 91 | 102 | $40,238 | $13,208 | 32.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 63 | 99 | $23,571 | $8,843 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 47 | 94 | $14,906 | $6,886 | 46.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 59 | 59 | $15,077 | $5,714 | 37.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 13 | 17 | $3,460 | $916.64 | 26.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 123 | 356 | $63,718 | $19,051 | 29.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 91 | 219 | $56,682 | $16,707 | 29.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 71 | 71 | $18,496 | $5,671 | 30.7% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 17 | 30 | $3,814 | $1,632 | 42.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 159 | 402 | $88,392 | $31,689 | 35.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 163 | 407 | $62,511 | $22,412 | 35.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 110 | 113 | $28,276 | $9,070 | 32.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $5,121 | $1,710 | 33.4% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 16 | 29 | $3,575 | $1,511 | 42.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 18 | 31 | $2,550 | $924.73 | 36.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 14 | 14 | $2,118 | $777.00 | 36.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 11 | 11 | $1,664 | $555.00 | 33.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 226 | 647 | $91,874 | $36,527 | 39.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 135 | 225 | $46,350 | $18,405 | 39.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 130 | 133 | $32,984 | $11,032 | 33.4% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2020 | 38 | 66 | $7,986 | $3,709 | 46.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $4,800 | $1,905 | 39.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 31 | 52 | $4,056 | $1,610 | 39.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 27 | 27 | $3,672 | $1,526 | 41.6% |
About Dr. Hala Alshayeb, MD
Dr. Hala Alshayeb, MD is a Internal Medicine healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942400452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hala Alshayeb, MD has received a total of $2,149 in payments from pharmaceutical and medical device companies, with $730.51 received in 2024. These payments were reported across 120 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,077).
As a Medicare-enrolled provider, Alshayeb has provided services to 1,836 Medicare beneficiaries, totaling 3,674 services with total Medicare billing of $248,600. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology, Nephrology
- Location Ashland, KY
- Active Since 07/23/2007
- Last Updated 01/24/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1942400452
Products in Payments
- LifeVest (Device) $254.34
- JYNARQUE (Drug) $233.42
- Kerendia (Drug) $159.42
- Veltassa (Drug) $151.78
- XARELTO (Drug) $83.12
- Sensipar (Drug) $76.58
- ACCRUFER (Drug) $71.05
- RAYALDEE (Drug) $65.15
- ACTHAR (Biological) $64.17
- Parsabiv (Biological) $56.29
- JARDIANCE (Drug) $51.26
- LUPKYNIS (Drug) $47.03
- ELIQUIS (Drug) $46.61
- Auryxia (Drug) $43.96
- FARXIGA (Drug) $43.15
- Velphoro (Drug) $40.77
- SAMSCA (Drug) $40.57
- SOLIRIS (Drug) $39.58
- CHANTIX (Drug) $39.03
- OSTEOCOOL RF ABLATION (Device) $38.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Ashland
Dr. Basel Edris, Md, MD
Internal Medicine — Payments: $42,620
Dr. Kenneth Leung, M.d, M.D
Internal Medicine — Payments: $10,085
Dr. Mehrdad Tavallaee, Md, MD
Internal Medicine — Payments: $6,878
Diane Settles, Md, MD
Internal Medicine — Payments: $6,278
Alexandr Karimov, M.d, M.D
Internal Medicine — Payments: $5,982
Roger Klein, M.d, M.D
Internal Medicine — Payments: $5,835